Caracterización biológica de dos aislados de Leptospira spp. procedentes de pacientes colombianos con síndrome de Weil
DOI:
https://doi.org/10.17533/udea.hm.5225Palavras-chave:
dosis letal 50, histopatología, leptospira, leptospirosis, modelo animalResumo
Downloads
Referências
Silva EF, Santos CS, Athanazio DA, Seyffert N, Seixas FK, Cerqueira GM, et al. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine. 2008; 26: 3892-6.
Ko AI, Goarant C y Picardeau M.Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nature Reviews. 2009; 7: 736-47.
Levett PN. Leptospirosis. Clin Microbiol Rev. 2001; 14: 296-326.
Pereira MM, Pereira JJ, Alves M, Da Silva MF, Pelajo M, Lenzi HL, et al. Experimental leptospirosis in Mar-moset Monkeys (Callithrix Jacchus): a new model for studies of severe pulmonary leptospirosis. Am J Trop Med Hyg. 2005; 72: 13-20.
Ko AI, Galvao RM, Ribeiro Dourado CM, Johnson WD, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999; 4: 820-5.
Faine S. Guidelines for the control of leptospirosis. Word Health Organization; Geneva: 1982.
Levett PN, Morey RE, Galloway RL, Turner DE, Stei-gerwaltand AG and Mayer LW. Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol. 2005; 54: 45-9.
Fajardo EM, Ortiz B, Chávez A, Gainza N, Izquierdo L, Hernández Y, et al. Estandarización de la dosis letal 50 de las cepas de Leptospira interrogans utilizadas en el control de la vacuna cubana contra la leptospirosis humana. Rev Cubana Med Trop. 1998; 50: 22-6.
Reed LJ, Muench H. A simple method of estimating the fifty percent endpoints. Am J Hyg. 1938; 27: 493-7.
Faine S, Adler B, Bolin C, Perolat P.Leptospira y leptospirosis. 2nd ed. Melbourne, Australia: MediSci; 1999.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-9.
Vernel PF, Merien F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun. 2006; 74: 4172-9.
Vernel PF, Goarant C. Differential Cytokine Gene Ex-pression According to Outcomeina Hamster Model of Leptospirosis. Neglected Tropical Diseases. 2010; 4: e582.
World Health Organization, International Leptospirosis Society. Human leptospirosis: guidance for diagnosis, surveillance and control 2003. [consultado 05/05/2006] Disponible en: http://www.med.monash.edu.au/microbiology/staff/adler/ilspage.html/
Hernández Y, Fajardo EM, Ortíz B. Método para revitalizar las cepas de Leptospira interrogans utilizadas en los ensayos de potencia de la vacuna antileptospirósica. Health IG; 1999. p. 7-11.
González A, Batista N, Valdés Y, González M. Crecimiento, virulencia y antigenicidad de Leptospirainterrogans serovar mozdok en medio EMJH modificado. Rev Cubana Med Trop. 2002; 54: 32-6.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2010 Hechos Microbiológicos
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.